Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 07, 2015 6:00 AM ET

Healthcare Providers and Services

Company Overview of N-of-One Therapeutics, Inc.

Company Overview

N-of-One Therapeutics, Inc. provides clinical analysis, curation, and interpretation of a tumor's molecular profile to providers, diagnostic companies, individual physicians, and cancer patients. The company’s solutions include treatment strategy roadmaps, clinical trial matching, and diagnostic strategy roadmaps. Its solutions and services pivot on matching patient-specific tumor molecular profiling data with knowledge on diagnostic technologies and therapeutic options to identify relevant clinical strategies for each patient's unique cancer. The company supports oncologists by delivering content and clinical insights for cancer treatment decisions and diagnostic approaches. N-of-One Therap...

430 Bedford Street

Suite 390

Lexington, MA 02420

United States

Founded in 2007

Phone:

617-202-9808

Fax:

781-652-8220

Key Executives for N-of-One Therapeutics, Inc.

Chairman and Chief Executive Officer
Age: 62
Founder, President, Chief Medical Officer and Director
Chief Financial Officer
Vice President of Operations
Chief Technology Officer
Compensation as of Fiscal Year 2014.

N-of-One Therapeutics, Inc. Key Developments

N-of-One, Inc. Announces Executive Appointments

N-of-One, Inc. announced the appointment of two senior executives to support the company's rapid growth. The company has created two new positions: Vice President of Sales and Vice President of Operations. Mark Balsano joins N-of-One in the newly created position of Vice President of Sales. Previously, Mark was Vice President of Sales at Response Genetics. Mark is an experienced sales leader in clinical diagnostics and diagnostic testing. He will be working closely with current N-of-One customers as well as new health networks and diagnostic labs interested in N-of-One solutions and services. Dave Stowell joins N-of-One in the newly created position of Vice President of Operations. Previously, Dave was Senior Vice President of Client Services for Optum and, prior to that, Dave was at Picis, a high acuity EMR company, as Senior Vice President of Client Management and Client Operations. Dave brings many years of operational experience in healthcare, and has the skills and experience to grow team to meet market demand. At N-of-One, Dave will lead daily operations, product management, solution implementation, and ongoing client management and support.

Intermountain Healthcare Selects N-of-One Inc. by to Provide Deep Clinical Interpretation for Cancer Genomics

N-of-One, Inc. announced an agreement with Intermountain Healthcare to provide clinical interpretation to Intermountain Healthcare as a key component of Intermountain's precision medicine services for oncology. Under the terms of the agreement, N-of-One will deliver clinical interpretation and analysis of the next-generation sequencing (NGS) test results of each patient's cancer. N-of-One's clinical interpretation links the relevant biological and clinical knowledge and insights related to the mutation profile of each tumor to therapeutic strategies.

CeGaT Selects N-of-One to Provide Clinical Interpretation for Next-Generation Sequencing Tests

CeGaT has announced an agreement with N-of-One, Inc. Under this agreement, N-of-One will provide clinical interpretation for CeGaT's next-generation sequencing (NGS) tests done for cancer patients. Financial terms of the agreement are not disclosed. CeGaT has developed a next-generation sequencing panel to analyze more than 550 cancer-relevant genes in a tumor sample simultaneously. Knowledge about the relevant mutations in a tumor helps clinicians select the most effective therapeutic strategies. CeGaT is partnering with N-of-One to provide high quality, up-to-date interpretation of mutations with very rapid turnaround times.

Similar Private Companies By Industry

Company Name Region
Pediatric Services of America, Inc. United States
Covington County Hospital United States
Herren Enterprises, Inc. United States
Vantus, Inc. United States
Administracion de Servicios Medicos de Puerto Rico United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact N-of-One Therapeutics, Inc., please visit www.n-of-one.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.